Study examines safety and early outcomes of gene therapy for spinal muscular atrophy

h s August 25, 2020

In May 2019, the U.S. Food and Drug Administration approved a gene replacement therapy for the inherited, progressive neuromuscular disease 5q-linked spinal muscular atrophy.

from News Medical Child Health News Feed https://ift.tt/2Qt618U